Cardiopulmonary bypass using lomoparan: monitoring of anticoagulation using anti-Xa levels and thromboelastography.
Sharma
S
S
Department of Cardiothoracic Surgery and Anaesthetics, Sir Charles Gairdner Hospital, Perth, Australia.
Newman
M
M
Gibbs
N
N
Parkinson
G
G
D000906:Antibodies / Q000097:blood*; D000925:Anticoagulants / Q000627:therapeutic use*; D000990:Antithrombin III / Q000378:metabolism*; D002315:Cardiopulmonary Bypass; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D003871:Dermatan Sulfate / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods*; D015951:Factor Xa / Q000276:immunology*; D006497:Heparan Sulfate / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013916:Thrombelastography
D000906:Antibodies; D000925:Anticoagulants; D000990:Antithrombin III; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D015951:Factor Xa; D006497:Heparan Sulfate; C035838:danaparoid